Skip to main content
. 2010 Apr 13;5(4):e10163. doi: 10.1371/journal.pone.0010163

Figure 4. Effects of wild type or mutant IRP2 transgenes in the expression of known downstream targets within the tumor xenograft.

Figure 4

(A) Extracts from tumor tissue were analyzed by Western blotting with antibodies against HA, TfR1, ferritin, ferroportin, DMT1 and β-actin. (B) Tumor extracts were analyzed for IRE-binding activity by EMSA with a 32P-labeled ferritin IRE probe. (C and D) Analysis of TfR1 and H-ferritin mRNA expression by qPCR.